NDC 0121-2697
Naprosyn
Naproxen
Naprosyn is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Pharmaceutical Associates, Inc.. The primary component is Naproxen.
| Product ID | 0121-2697_ab103f7e-dd64-d3dc-e053-2995a90a3c7c |
| NDC | 0121-2697 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Naprosyn |
| Generic Name | Naproxen |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA018965 |
| Labeler Name | Pharmaceutical Associates, Inc. |
| Substance Name | NAPROXEN |
| Active Ingredient Strength | 500 mg/20mL |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0121-2697-22
10 TRAY in 1 CASE (0121-2697-22) > 10 CUP, UNIT-DOSE in 1 TRAY > 20 mL in 1 CUP, UNIT-DOSE (0121-2697-20)
| Marketing Start Date | 2020-07-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "Naprosyn" or generic name "Naproxen"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0121-0899 | Naprosyn | Naproxen |
| 0121-1798 | Naprosyn | Naproxen |
| 0121-2697 | Naprosyn | Naproxen |
| 69437-316 | Naprosyn | Naprosyn |
| 71511-701 | Naprosyn | Naprosyn |
| 80425-0048 | Naprosyn | Naprosyn |
| 80425-0051 | Naprosyn | Naprosyn |
| 80425-0050 | Naprosyn | Naprosyn |
| 80425-0049 | Naprosyn | Naprosyn |
| 80425-0010 | Naprosyn | Naprosyn |
| 0363-9609 | BACK AND MUSCLE PAIN | NAPROXEN |
| 0004-6415 | EC-Naprosyn | naproxen |
| 0054-3630 | Naproxen | Naproxen |
| 0093-1005 | Naproxen | Naproxen |
| 0093-1006 | Naproxen | Naproxen |
| 0143-1346 | Naproxen | Naproxen |
| 0143-1347 | Naproxen | Naproxen |
| 0143-1348 | Naproxen | Naproxen |
| 0179-1978 | Naproxen | Naproxen |
| 0440-1852 | Naproxen | Naproxen |
| 0440-7852 | Naproxen | Naproxen |
| 0615-1504 | Naproxen | Naproxen |
| 0615-3562 | Naproxen | Naproxen |
| 0615-3563 | Naproxen | Naproxen |
| 0615-7709 | Naproxen | Naproxen |
| 0615-7892 | Naproxen | Naproxen |
| 0615-8094 | Naproxen | Naproxen |
| 10544-010 | Naproxen | Naproxen |
| 10544-016 | Naproxen | Naproxen |
| 10544-019 | Naproxen | Naproxen |
| 10544-044 | Naproxen | Naproxen |
| 10544-061 | Naproxen | Naproxen |
| 10544-111 | NAPROXEN | NAPROXEN |
| 10544-277 | Naproxen | Naproxen |
| 10544-278 | Naproxen | Naproxen |
| 10544-920 | Naproxen | Naproxen |
| 10544-922 | Naproxen | Naproxen |
| 10544-939 | Naproxen | Naproxen |
| 12634-498 | Naproxen | Naproxen |
| 12634-684 | Naproxen | Naproxen |
| 21695-084 | Naproxen | Naproxen |
| 21695-085 | Naproxen | Naproxen |
Trademark Results [Naprosyn]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NAPROSYN 72406172 0951192 Live/Registered |
SYNTEX LABORATORIES, INC. 1971-10-27 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.